Private Equity Firms Line up for Merck KGaA’s Generics

Private equity capital companies Cinven, Texas Pacific Group, and Permira are among companies that have expressed an interest in acquiring Merck KGaA’s generic drugs business, which is up for sale, according to German press reports last week (CW, Jan. 17, p. 23). Meanwhile, Ranbaxy (Gurgaon, India), India’s biggest manufacturer of pharmaceuticals, says it is considering teaming up with a private equity firm to bid for Merck KGaA’s generics. Pharma manufacturers Actavis (Hafnarfjordur, Iceland) and Sanofi-Aventis may also be interested in buying...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers